OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
8
Results
Show all
Save search
Copy query
Show results for
Unknown
(8)
Publication Date
Release Date
2022
(2)
2021
(2)
2025
(1)
2024
(1)
2023
(1)
2020
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Mer Tyrosine Kinase (MERTK) modulates liver fibrosis progression and hepatocellular carcinoma development.
Not available
S-EPMC9394453
|
biostudies-literature
Cite
First-Line Immune Checkpoint Inhibitor-Based Sequential Therapies for Advanced Hepatocellular Carcinoma: Rationale for Future Trials.
Not available
S-EPMC8820155
|
biostudies-literature
Cite
Antiplatelet Therapy with Cangrelor in Patients Undergoing Surgery after Coronary Stent Implantation: A Real-World Bridging Protocol Experience.
Not available
S-EPMC7758156
|
biostudies-literature
Cite
Real-world experience with long-term albumin in patients with cirrhosis and ascites.
Not available
S-EPMC11617394
|
biostudies-literature
Cite
Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naive Patients With Primary Biliary Cholangitis: A Dual Cut-Off Approach.
Not available
S-EPMC8518641
|
biostudies-literature
Cite
Liver and cardiovascular mortality after hepatitis C virus eradication by DAA: Data from RESIST-HCV cohort.
Not available
S-EPMC8359835
|
biostudies-literature
Cite
Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease.
Not available
S-EPMC10393808
|
biostudies-literature
Cite
Long-term effectiveness, safety, and liver stiffness dynamics of PBC treatment with obeticholic acid in real-world.
Not available
S-EPMC12276448
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets